日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Artificial Intelligence and Prostate–Breast Cancer Biology: Recent Advances in Treatments and Perspectives — A Comprehensive Review

人工智能与前列腺癌-乳腺癌生物学:治疗和展望的最新进展——一项综合综述

Pashtan, Itai M; Recht, Abram; Ancukiewicz, Marek; Brachtel, Elena; Abi-Raad, Rita F; D'Alessandro, Helen A; Levy, Antonin; Wo, Jennifer Y; Hirsch, Ariel E; Kachnic, Lisa A; Goldberg, Saveli; Specht, Michelle; Gadd, Michelle; Smith, Barbara L; Powell, Simon N; Taghian, Alphonse G; Ouma, Russell B O; Ngari, Silas M; Kibet, Joshua K

Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II Study

Balstilimab 和 Zalifrelimab 联合双重 PD-1 和 CTLA-4 检查点阻断作为晚期宫颈癌二线治疗:一项开放标签 II 期研究

O'Malley, David M; Neffa, Maryna; Monk, Bradley J; Melkadze, Tamar; Huang, Marilyn; Kryzhanivska, Anna; Bulat, Iurie; Meniawy, Tarek M; Bagameri, Andrea; Wang, Edward W; Doger de Speville Uribe, Bernard; Hegg, Roberto; Ortuzar Feliu, Waldo; Ancukiewicz, Marek; Lugowska, Iwona

Potential Circulating Biomarkers of Recurrence after Hepatic Resection or Liver Transplantation in Hepatocellular Carcinoma Patients

肝细胞癌患者肝切除或肝移植术后复发的潜在循环生物标志物

Duda, Dan G; Dima, Simona O; Cucu, Dana; Sorop, Andrei; Klein, Sebastian; Ancukiewicz, Marek; Kitahara, Shuji; Iacob, Speranta; Bacalbasa, Nicolae; Tomescu, Dana; Herlea, Vlad; Tanase, Cristiana; Croitoru, Adina; Popescu, Irinel

Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2

肥胖通过上调IL-6和潜在的FGF-2,促进乳腺癌对VEGF抑制剂的耐药性。

Incio, Joao; Ligibel, Jennifer A; McManus, Daniel T; Suboj, Priya; Jung, Keehoon; Kawaguchi, Kosuke; Pinter, Matthias; Babykutty, Suboj; Chin, Shan M; Vardam, Trupti D; Huang, Yuhui; Rahbari, Nuh N; Roberge, Sylvie; Wang, Dannie; Gomes-Santos, Igor L; Puchner, Stefan B; Schlett, Christopher L; Hoffmman, Udo; Ancukiewicz, Marek; Tolaney, Sara M; Krop, Ian E; Duda, Dan G; Boucher, Yves; Fukumura, Dai; Jain, Rakesh K

Long-term quality of life after definitive treatment for prostate cancer: patient-reported outcomes in the second posttreatment decade

前列腺癌根治性治疗后的长期生活质量:治疗后第二个十年患者报告的结果

Jang, Joanne W; Drumm, Michael R; Efstathiou, Jason A; Paly, Jonathan J; Niemierko, Andrzej; Ancukiewicz, Marek; Talcott, James A; Clark, Jack A; Zietman, Anthony L

A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients

一项针对新诊断的胶质母细胞瘤患者进行放疗和替莫唑胺联合或不联合凡德他尼治疗的多中心、II 期、随机、非对比临床试验

Eudocia Q Lee, Thomas J Kaley, Dan G Duda, David Schiff, Andrew B Lassman, Eric T Wong, Tom Mikkelsen, Benjamin W Purow, Alona Muzikansky, Marek Ancukiewicz, Jason T Huse, Shakti Ramkissoon, Jan Drappatz, Andrew D Norden, Rameen Beroukhim, Stephanie E Weiss, Brian M Alexander, Christine S McCluskey,

Cardiac and inflammatory biomarkers do not correlate with volume of heart or lung receiving radiation

心脏和炎症生物标志物与接受辐射的心脏或肺脏体积无关

Kuo, Angera H; Ancukiewicz, Marek; Kozak, Kevin R; Yock, Torunn I; Padera, Timothy P

Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients

血管密度和正常化在乳腺癌患者新辅助贝伐单抗和化疗中的作用

Sara M Tolaney, Yves Boucher, Dan G Duda, John D Martin, Giorgio Seano, Marek Ancukiewicz, William T Barry, Shom Goel, Johanna Lahdenrata, Steven J Isakoff, Eren D Yeh, Saloni R Jain, Mehra Golshan, Jane Brock, Matija Snuderl, Eric P Winer, Ian E Krop, Rakesh K Jain

Improved tumor vascularization after anti-VEGF therapy with carboplatin and nab-paclitaxel associates with survival in lung cancer

卡铂和白蛋白紫杉醇抗 VEGF 治疗后肿瘤血管化改善与肺癌生存相关

Rebecca S Heist, Dan G Duda, Dushyant V Sahani, Marek Ancukiewicz, Panos Fidias, Lecia V Sequist, Jennifer S Temel, Alice T Shaw, Nathan A Pennell, Joel W Neal, Leena Gandhi, Thomas J Lynch, Jeffrey A Engelman, Rakesh K Jain

A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma.

一项针对可切除胰腺导管腺癌的术前短期放化疗(质子束疗法和卡培他滨)后早期手术的 1/2 期生物标志物研究

Hong Theodore S, Ryan David P, Borger Darrell R, Blaszkowsky Lawrence S, Yeap Beow Y, Ancukiewicz Marek, Deshpande Vikram, Shinagare Shweta, Wo Jennifer Y, Boucher Yves, Wadlow Raymond C, Kwak Eunice L, Allen Jill N, Clark Jeffrey W, Zhu Andrew X, Ferrone Cristina R, Mamon Harvey J, Adams Judith, Winrich Barbara, Grillo Tarin, Jain Rakesh K, DeLaney Thomas F, Fernandez-del Castillo Carlos, Duda Dan G